Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-4 vs TB-500: Research Comparison

Amino Acid Length 43 amino acids 17–23 amino acids (active fragment) TB-500's shorter sequence eliminates degradation-prone regions without sacrificing core actin-binding function Molecular Weight ~4,921 Da ~1,974 Da Lower molecular weight improves tissue pene

This comparison does not assign a generated winner or score.

  • Amino Acid Length
  • 43 amino acids
  • 17–23 amino acids (active fragment)
  • TB-500's shorter sequence eliminates degradation-prone regions without sacrificing core actin-binding function
  • Molecular Weight
  • ~4,921 Da
  • ~1,974 Da
  • Lower molecular weight improves tissue penetration and reduces immunogenicity risk in animal models
  • Stability (Reconstituted, 2–8°C)
  • 7–10 days at >90% potency
  • 28+ days at >95% potency
  • TB-500's extended stability window reduces protocol failures from peptide degradation mid-study
  • Plasma Half-Life (Rodent Models)
  • ~2.5 hours
  • 6–8 hours
  • Longer half-life allows less frequent dosing, improving animal welfare compliance and reducing handling variables
  • Cost per Functional Unit
  • $180–$320 per 5mg (vendor dependent)
  • $45–$95 per 5mg (vendor dependent)
  • TB-500 delivers 60–75% cost reduction per milligram without meaningful functional compromise in most assays
  • Actin-Binding Activity
  • 100% (reference standard)
  • 85–95% (varies by assay)
  • Functional difference is statistically insignificant in migration and wound healing models
  • Secondary Pathway Activation (FAK, ILK)
  • Full integrin signalling modulation
  • Partial replication (~50–60% of TB-4 effect)
  • Relevant only if your research question explicitly targets integrin-mediated pathways beyond actin dynamics
  • Bottom Line
  • Required for studies investigating TB-4's full signalling profile, including immune modulation and cardiac differentiation
  • Optimal for wound healing, angiogenesis, and migration assays where actin sequestration is the primary mechanism
  • Choose TB-500 unless your protocol specifically requires secondary signalling pathways that TB-500 does not fully replicate
More references

Related material

Comparison

TB-4 vs TB-500: Pros and Cons

Source Natural human protein Synthetic fragment Molecular Size Larger, complex Smaller, more stable Bioavailability Lower when injected or applied topically Higher tissue penetrat…

View details →